China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.9800
-0.0800 (-7.55%)
Aug 21, 2026, 4:00 PM EDT - Market closed

China Pharma Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.914.144.537.018.19.64
Revenue Growth
-10.97%-8.49%-35.41%-13.48%-15.95%-11.27%
Gross Profit
0.46-0.13-1.99-0.28-0.490.35
Operating Income
-4.38-3.09-4.59-2.75-3.55-2.86
Net Income
-4.47-3.19-4.74-3.08-3.97-3.4
Earnings Per Share
-0.23-0.74-2.71-9.10-37.79-36.85
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.30.350.631.422.034.86
Total Debt
3.753.893.754.638.7612.49
Net Cash (Debt)
-3.45-3.54-3.12-3.21-6.73-7.63
Net Cash Growth
------
Net Cash Per Share
-0.17-0.83-1.79-9.49-63.99-82.69

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.160.15-0.41-0.7-0.41-0.25
Capital Expenditures
-0-0.06-0.04-0.01-0.4-0.44
Free Cash Flow
-0.160.09-0.44-0.71-0.81-0.69
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
11.76%-3.18%-43.84%-4.01%-6.09%3.62%
Operating Margin
-111.82%-74.50%-101.32%-39.25%-43.79%-29.67%
Pretax Margin
-114.33%-76.91%-104.58%-43.91%-49.02%-35.26%
Profit Margin
-114.33%-76.92%-104.58%-43.91%-49.02%-35.26%
FCF Margin
-4.04%2.15%-9.81%-10.14%-10.01%-7.13%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
-68.33----
PS Ratio
10.771.470.990.570.612.37